Nearly half of Type 2 diabetes patients suffer from micronutrient deficiencies, with vitamin D and magnesium being the most ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Micronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...

Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

FRIDAY, Jan. 24, 2025 (HealthDay News) -- People can reverse their type 2 diabetes through a combination of calorie cutting ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor ...